Diabetes medications and cardiovascular outcome trials: Lessons learned

Kershaw V. Patel, Natalia De Albuquerque Rocha, Darren K McGuire

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

The US Food and Drug Administration's current standards require that new diabetes medications demonstrate cardiovascular safety in large, long-term trials. New drugs that have been assessed in such trials are changing the management of type 2 diabetes.

Original languageEnglish (US)
Pages (from-to)759-767
Number of pages9
JournalCleveland Clinic Journal of Medicine
Volume84
Issue number10
DOIs
StatePublished - 2017

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Diabetes medications and cardiovascular outcome trials: Lessons learned'. Together they form a unique fingerprint.

  • Cite this